![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, August 17, 2004 1:03:25 PM
The most profoundly exciting item for our future as DNAP investors is the statement you quoted at the end of your post...
"DNAPrint's success with this difficult trait has profound implications for its goal of developing a pipeline of small molecule drugs that target specific human subpopulations..."
We are witnessing the dawning of a young innovative pharmacogenomics company that can mine the complex traits of the human genome.
DNAP...What an incredible company with awesome technology...!
Thanks!
God Bless and take care,
Robert
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM